Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
A 115.53 -0.26% -0.30
ABBV closed down 0.26 percent on Wednesday, June 16, 2021, on 1.24 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical ABBV trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.11%
MACD Bullish Signal Line Cross Bullish 0.10%
Inside Day Range Contraction 0.10%
Crossed Above 20 DMA Bullish -0.61%
MACD Bullish Centerline Cross Bullish -0.61%
MACD Bearish Centerline Cross Bearish 2.23%
Up 3 Days in a Row Strength 2.23%
Oversold Stochastic Weakness 2.23%
NR7 Range Contraction 2.82%
Lower Bollinger Band Walk Weakness 2.82%
Older End-of-Day Signals for ABBV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AbbVie Inc. Description

AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Acid Pharmaceutical Products Autoimmune Diseases Chemical Compounds Organic Compounds Prostate Cancer Autoimmune Disease Distribution Center Thyroid Cardiology Anesthesia Cholesterol Respiratory Disease Chloroarenes Testosterone Triglyceride Carbidopa Gabaa Receptor Positive Allosteric Modulators Hyperparathyroidism Advanced Prostate Cancer Low Density Lipoprotein Niacin Secondary Hyperparathyroidism Anesthesia Product Celiac Celiac Disease Exocrine Pancreatic Insufficiency Hypothyroidism Lipoproteins Research Based Biopharmaceutical Testosterone Replacement Therapy

Is ABBV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 118.28
52 Week Low 79.11
Average Volume 5,348,083
200-Day Moving Average 103.05
50-Day Moving Average 112.76
20-Day Moving Average 114.29
10-Day Moving Average 114.23
Average True Range 1.80
ADX 17.42
+DI 26.95
-DI 18.61
Chandelier Exit (Long, 3 ATRs) 112.88
Chandelier Exit (Short, 3 ATRs) 116.05
Upper Bollinger Bands 117.70
Lower Bollinger Band 110.88
Percent B (%b) 0.68
BandWidth 5.97
MACD Line 0.55
MACD Signal Line 0.41
MACD Histogram 0.1444
Fundamentals Value
Market Cap 203.96 Billion
Num Shares 1.77 Billion
EPS 4.57
Price-to-Earnings (P/E) Ratio 25.27
Price-to-Sales 4.13
Price-to-Book 12.13
PEG Ratio 1.28
Dividend 5.20
Dividend Yield 4.50%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 117.56
Resistance 3 (R3) 117.67 117.10 117.22
Resistance 2 (R2) 117.10 116.58 117.04 117.11
Resistance 1 (R1) 116.31 116.26 116.03 116.21 117.00
Pivot Point 115.74 115.74 115.60 115.69 115.74
Support 1 (S1) 114.96 115.22 114.67 114.85 114.06
Support 2 (S2) 114.39 114.90 114.33 113.95
Support 3 (S3) 113.60 114.39 113.84
Support 4 (S4) 113.50